Ishemik yurak kasalligi aniqlangan xavf omillari va D vitamini darajalari o‘rtasidagi o‘zaro bog‘liqlikning korrelyatsion tahlili

P. Autier, M. Boniol, C. Pizot, P. Mullie, Vitamin D status and ill health: A systematic review, Lancet Diabetes Endocrinology, 2014, 2, 76–89.

A. Chanakul, M.Y.H. Zhang, A. Louw, H.J. Armbrecht, W.L. Miller, A.A. Portale, F. Perwad, FGF-23 regulates CYP27B1 transcription in the kidney and in extra-renal tissues, PLoS ONE, 2013, 8, e72816.

S. Chen, D.J. Glenn, W. Ni, C.L. Grigsby, K. Olsen, M. Nishimoto, C.S. Law, D.G. Gardner, Expression of the vitamin D receptor is increased in the hypertrophic heart, Hypertension, 2008, 52, 1106–1112.

G. Jahreis, V. Hesse, Vitamin D-induced tissue calcinosis and arteriosclerosis changes. I: A contribution to the 60-year history of vitamin D research with special reference to childhood, Padiatrische Grenzgebiete, 1990, 29, 03, 203–211.

I. Karampela, A. Sakelliou, N. Vallianou, G.S. Christodoulatos, F. Magkos, M. Dalamaga, Vitamin D and Obesity: Current Evidence and Controversies, Current Obesity Reports, 2021, 10, 02, 162–180.

N. Latic, R.G. Erben, Vitamin D and Cardiovascular Disease, with Emphasis on Hypertension, Atherosclerosis, and Heart Failure, International Journal of Molecular Sciences, 2020, 21, 6483.

Y.A. Lee, S.G. Kang, S.W. Song, S.H. Kim, Association between Homocysteine and Vitamin D Levels in Asymptomatic Korean Adults, Nutrients, 2024, 16, 08, 1155.

P.E. Norman, J.T. Powell, Vitamin D and cardiovascular disease, Circulation Research, 2014, 114, 379–393.

S. Pilz, W. Ma¨rz, K.D. Cashman, M.E. Kiely, S.J. Whiting, M.F. Holick, W.B. Grant, P. Pludowski, M. Hiligsmann, C. Trummer, Rationale and Plan for Vitamin D Food Fortification: A Review and Guidance Paper, Frontiers in Endocrinology, 2018, 9, 373.

S. Pilz, N. Verheyen, M.R. Gru¨ bler, A. Tomaschitz, W. Ma¨rz, Vitamin D and cardiovascular disease prevention, Nature Reviews Cardiology, 2016, 13, 404–417.

M.P. Ponda, K. Dowd, D. Finkielstein, P.R. Holt, J.L. Breslow, The short-term effects of vitamin D repletion on cholesterol: a randomized, placebo-controlled trial, Arteriosclerosis, Thrombosis, and Vascular Biology, 2012, 32, 010, 2510–2515.

G.A. Roth, C. Johnson, A. Abajobir, F. Abd-Allah, S.F. Abera, G. Abyu, M. Ahmed, B. Aksut, T. Alam, K. Alam, Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015, Journal of the American College of Cardiology, 2017, 70, 1–25, 10.1016/j.jacc.2017.04.052.

J.J. Scialla, M. Wolf, Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease, Nature Reviews Nephrology, 2014, 10, 268–278.

D. Somjen, Y. Weisman, F. Kohen, B. Gayer, R. Limor, O. Sharon, N. Jaccard, E. Knoll, N. Stern, 25-Hydroxyvitamin D3-1-Hydroxylase Is Expressed in Human Vascular Smooth Muscle Cells and Is Upregulated by Parathyroid Hormone and Estrogenic Compounds, Circulation, 2005, 111, 1666–1671.

Y. Song, L. Wang, A.G. Pittas, Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies, Diabetes Care, 2013, 36, 05, 1422–1428.

A.M. Surdu, O. Pˆınzariu, D.M. Ciobanu, Vitamin D and Its Role in the Lipid Metabolism and the Development of Atherosclerosis, Biomedicines, 2021, 9, 02, 172.

L.Yang, H. Zhao, K. Liu, Smoking behavior and circulating vitamin D levels in adults: A meta-analysis, Food Science Nutrition, 2021, 9, 010, 5820–5832.

A. Zittermann, S.S. Schleithoff, G. Tenderich, H.K. Berthold, R. Ko¨rfer, P. Stehle, Low vitamin D status: A contributing factor in the pathogenesis of congestive heart failure, Journal of the American College of Cardiology, 2003, 41, 105–112.